Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Judith G, Villablanca"'
Autor:
Kelly C. Goldsmith, Julie R. Park, Kimberly Kayser, Jemily Malvar, Yueh-Yun Chi, Susan G. Groshen, Judith G. Villablanca, Kateryna Krytska, Lillian M. Lai, Patricia T. Acharya, Fariba Goodarzian, Bruce Pawel, Hiroyuki Shimada, Susan Ghazarian, Lisa States, Lynley Marshall, Louis Chesler, Meaghan Granger, Ami V. Desai, Rajen Mody, Daniel A. Morgenstern, Suzanne Shusterman, Margaret E. Macy, Navin Pinto, Gudrun Schleiermacher, Kieuhoa Vo, Holger C. Thurm, Joseph Chen, Marlon Liyanage, Gerson Peltz, Katherine K. Matthay, Esther R. Berko, John M. Maris, Araz Marachelian, Yael P. Mossé
Publikováno v:
Nature Medicine. 29:1092-1102
Neuroblastomas harbor ALK aberrations clinically resistant to crizotinib yet sensitive pre-clinically to the third-generation ALK inhibitor lorlatinib. We conducted a first-in-child study evaluating lorlatinib with and without chemotherapy in childre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05cb1069b5caae85576f8251b56aaa50
https://doi.org/10.1038/s41591-023-02297-5
https://doi.org/10.1038/s41591-023-02297-5
Autor:
Katherine K. Matthay, Araz Marachelian, Judith G. Villablanca, Denice Tsao-Wei, Scarlett Czarnecki, Hiroyuki Shimada, Fariba Goodarzian, Hollie Jackson, Jesse Courtier, Randall Hawkins, Gregory A. Yanik, M. Meaghan Granger, Susan L. Cohn, Brian Weiss, Kathy Giacomini, Eugene Chen, Ethan Geier, Xiaodong Yang, Daphne A. Haas-Kogan, Julie R. Park, Susan Groshen, Steven G. DuBois
Purpose: 131I-metaiodobenzylguanidine (MIBG) is a radiopharmaceutical with activity in neuroblastoma. Vorinostat is a histone deacetylase inhibitor that has radiosensitizing properties. The goal of this phase I study was to determine the MTDs of vori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3554100df37e38a8e97ee7720709512e
https://doi.org/10.1158/1078-0432.c.6524513
https://doi.org/10.1158/1078-0432.c.6524513
Autor:
Robert C. Seeger, Richard Sposto, Shahab Asgharzadeh, Susan Groshen, Katherine K. Matthay, Meaghan Granger, Kelly Goldsmith, Brian D. Weiss, Rebekah Kennedy, Scarlett Czarnecki, Sabrina Young, Nora Bedrossian, Richard Gallego, Jaime A. Parra, Hung C. Tran, Hiroyuki Shimada, Hollie A. Lai, Fariba Goodarzian, Betty Liu, Cathy W. Liu, Judith G. Villablanca, Araz Marachelian
Supplementary Figure Legends for A1-A3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00dce7f361a6740c645a34524574b2e8
https://doi.org/10.1158/1078-0432.22467864
https://doi.org/10.1158/1078-0432.22467864
Autor:
Katherine K. Matthay, Araz Marachelian, Judith G. Villablanca, Denice Tsao-Wei, Scarlett Czarnecki, Hiroyuki Shimada, Fariba Goodarzian, Hollie Jackson, Jesse Courtier, Randall Hawkins, Gregory A. Yanik, M. Meaghan Granger, Susan L. Cohn, Brian Weiss, Kathy Giacomini, Eugene Chen, Ethan Geier, Xiaodong Yang, Daphne A. Haas-Kogan, Julie R. Park, Susan Groshen, Steven G. DuBois
Supplemental Figure 1. PCR cycle count for NET mRNA expression in peripheral blood mononuclear cells from 7 patients obtained on Day 1 and/or 3 of protocol therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::568719a7183defb09ed226724ee787e2
https://doi.org/10.1158/1078-0432.22460495.v1
https://doi.org/10.1158/1078-0432.22460495.v1
Autor:
Robert C. Seeger, Richard Sposto, Shahab Asgharzadeh, Susan Groshen, Katherine K. Matthay, Meaghan Granger, Kelly Goldsmith, Brian D. Weiss, Rebekah Kennedy, Scarlett Czarnecki, Sabrina Young, Nora Bedrossian, Richard Gallego, Jaime A. Parra, Hung C. Tran, Hiroyuki Shimada, Hollie A. Lai, Fariba Goodarzian, Betty Liu, Cathy W. Liu, Judith G. Villablanca, Araz Marachelian
Table A1. Therapies received for samples submitted on this study; Table A2. Genes and Primer and Probe Sets for NB5 assay; Table A3. Clinical Evaluations and NB5 TLDA Assays Performed; Table A4. Contribution of Individual Gene to NB5 Signature and AU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8487e4dc6c60a39dcb15f2cfbc47d008
https://doi.org/10.1158/1078-0432.22467867
https://doi.org/10.1158/1078-0432.22467867
Autor:
Robert C. Seeger, Richard Sposto, Shahab Asgharzadeh, Susan Groshen, Katherine K. Matthay, Meaghan Granger, Kelly Goldsmith, Brian D. Weiss, Rebekah Kennedy, Scarlett Czarnecki, Sabrina Young, Nora Bedrossian, Richard Gallego, Jaime A. Parra, Hung C. Tran, Hiroyuki Shimada, Hollie A. Lai, Fariba Goodarzian, Betty Liu, Cathy W. Liu, Judith G. Villablanca, Araz Marachelian
Comparison of 1 year EFS in two groups defined by a range of ∆CT cut points (left column) and corresponding ROC analysis of the ability of ∆CT values above the cutpoint to predict 1 year EFS (right column), for assays base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50e437b8d7e2e074bbeb8625cd9ae491
https://doi.org/10.1158/1078-0432.22467870.v1
https://doi.org/10.1158/1078-0432.22467870.v1
Autor:
Robert C. Seeger, Richard Sposto, Shahab Asgharzadeh, Susan Groshen, Katherine K. Matthay, Meaghan Granger, Kelly Goldsmith, Brian D. Weiss, Rebekah Kennedy, Scarlett Czarnecki, Sabrina Young, Nora Bedrossian, Richard Gallego, Jaime A. Parra, Hung C. Tran, Hiroyuki Shimada, Hollie A. Lai, Fariba Goodarzian, Betty Liu, Cathy W. Liu, Judith G. Villablanca, Araz Marachelian
Purpose: We determined whether quantifying neuroblastoma-associated mRNAs (NB-mRNAs) in bone marrow and blood improves assessment of disease and prediction of disease progression in patients with relapsed/refractory neuroblastoma.Experimental Design:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fe62367e5d384c48aad242b6f3626cf
https://doi.org/10.1158/1078-0432.c.6526767.v1
https://doi.org/10.1158/1078-0432.c.6526767.v1
Autor:
Julie R. Park, Judith G. Villablanca, Barbara Hero, Brian H. Kushner, Keith Wheatley, Klaus H. Beiske, Ruth L. Ladenstein, Sylvain Baruchel, Margaret E. Macy, Lucas Moreno, Nita L. Seibel, Andrew D. Pearson, Katherine K. Matthay, Dominique Valteau‐Couanet
Publikováno v:
Scientia
Consensus criteria; Early phase; Neuroblastoma Criteris de consens; Fase inicial; Neuroblastoma Criterios de consenso; Fase inicial; Neuroblastoma Background International standardized criteria for eligibility, evaluable disease sites, and disease re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4711429cdcf9a6fa3103d79471929a72
https://pubmed.ncbi.nlm.nih.gov/36101004
https://pubmed.ncbi.nlm.nih.gov/36101004
Autor:
Yael P. Mosse, Brian Weiss, Fariba Goodarzian, Navin Pinto, Judith G. Villablanca, Gregory A. Yanik, Scarlett Czarnecki, Suzanne Shusterman, Araz Marachelian, Anasheh Shamirian, Hiroyuki Shimada, Rachel Berkovich, John M. Maris, Daphne A. Haas-Kogan, Julie R. Park, M. Meaghan Granger, Clare J. Twist, Steven G. DuBois, Lingyun Ji, Kieuhoa T. Vo, Susan L. Cohn, Katherine K. Matthay, Denice D. Tsao-Wei, Kelly C. Goldsmith, Susan Groshen, Meredith S. Irwin
Publikováno v:
J Clin Oncol
PURPOSE 131I-metaiodobenzylguanidine (MIBG) is an active radiotherapeutic for neuroblastoma. The primary aim of this trial was to identify which of three MIBG regimens was likely associated with the highest true response rate. PATIENTS AND METHODS Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5465588083dc929da824e7729c79092
https://europepmc.org/articles/PMC8547934/
https://europepmc.org/articles/PMC8547934/
Autor:
Wendy Fitzgerald, Luke Pater, Heidi V. Russell, Brian Weiss, Hiroyuki Shimada, Yael P. Mosse, Julie R. Park, Arlene Naranjo, Barry L. Shulkin, Hollie Lai, Judith G. Villablanca, Fan F Zhang, Roger Giller, Jason A. Jarzembowski, Rochelle Bagatell, Peter Mattei, Gregory A. Yanik, Stephan A. Grupp, Marguerite T. Parisi, Katherine K. Matthay
Publikováno v:
Pediatr Blood Cancer
INTRODUCTION: (131)I-metaiodobenzylguanidine ((131)I-MIBG) is effective in relapsed neuroblastoma. The Children’s Oncology Group (COG) conducted a pilot study (NCT01175356) to assess tolerability and feasibility of induction chemotherapy followed b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eb2eb33f779ce8363a4a3ed78399459
https://europepmc.org/articles/PMC9150928/
https://europepmc.org/articles/PMC9150928/